共 50 条
- [2] Common Deficiencies with Bioequivalence Submissions in Abbreviated New Drug Applications Assessed by FDA AAPS JOURNAL, 2012, 14 (01): : 19 - 22
- [3] Common Deficiencies with Bioequivalence Submissions in Abbreviated New Drug Applications Assessed by FDA The AAPS Journal, 2012, 14 : 19 - 22
- [4] Common Filing Deficiencies in Abbreviated New Drug Applications Containing Clinical Endpoint Studies Therapeutic Innovation & Regulatory Science, 2019, 53 : 81 - 85
- [6] Common Deficiencies of in vitro Binding Bioequivalence (BE) Studies Submitted in Abbreviated New Drug Applications (ANDAs) AAPS JOURNAL, 2018, 20 (02):